Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$3.56 - $4.64 $356 - $463
-100 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$3.95 - $5.41 $395 - $541
100 New
100 $0
Q1 2021

May 17, 2021

SELL
$4.52 - $7.8 $19,887 - $34,320
-4,400 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.56 - $26.93 $37,664 - $118,492
4,400 New
4,400 $40,000

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.